These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20806416)

  • 1. Anaphylactoid-like reactions in a patient with HyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric.
    Adamski J; Jamensky L; Ross J; Siegel DL; Sachais BS
    J Clin Apher; 2010; 25(6):354-7. PubMed ID: 20806416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
    Sosland RP; Gollub SB; Wilson DB; Moriarty PM
    Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor.
    Koga N; Nagano T; Sato T; Kagasawa K
    ASAIO J; 1993; 39(3):M288-91. PubMed ID: 8268545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid reductions by low-density lipoprotein apheresis: a comparison of three systems.
    Jovin IS; Taborski U; Stehr A; Müller-Berghaus G
    Metabolism; 2000 Nov; 49(11):1431-3. PubMed ID: 11092506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact activation in low-density lipoprotein apheresis systems.
    Krieter DH; Steinke J; Kerkhoff M; Fink E; Lemke HD; Zingler C; Müller GA; Schuff-Werner P
    Artif Organs; 2005 Jan; 29(1):47-52. PubMed ID: 15644083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL apheresis: a novel technique (LIPOCOLLECT 200).
    Stefanutti C; Di Giacomo S; Mazzarella B; Castelli A
    Artif Organs; 2009 Dec; 33(12):1103-8. PubMed ID: 19995360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of lipoprotein (a) using the regenerate of a dextran sulfate cellulose LDL apheresis system.
    Gross E; März W; Siekmeier R; Scharrer I; Gross W
    Protein Expr Purif; 1994 Apr; 5(2):112-7. PubMed ID: 8054842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
    Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
    Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran-sulfate cellulose adsorption for lowering Lp[a].
    Parker TS
    Chem Phys Lipids; 1994 Jan; 67-68():331-8. PubMed ID: 8187231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Klinkmann J; Latza R
    J Clin Apher; 1996; 11(2):78-80. PubMed ID: 8844436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL apheresis with dextran sulfate and angiotension receptor antagonist (Losartan).
    Elicio N; Bertolini S; Garbarini R; Nardiello G; Elicio A; Aimale V
    Artif Organs; 1997 Apr; 21(4):334-5. PubMed ID: 9096809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
    Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
    J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein apheresis: plasma exchange or dextran sulfate adsorption apheresis.
    Yavasoglu I; Kadikoylu G; Bolaman Z
    Ther Apher Dial; 2008 Feb; 12(1):100-1; author reply 102. PubMed ID: 18257822
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
    Koga N
    Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
    Moriarty P; Sosland R; Gibson C; Belmont J
    Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
    Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
    Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.